Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited

Chan Yeu Pu¹, Sai Yendamuri^{2

3}

Affiliations

¹ Pulmonary, Critical Care and Sleep Division, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, NY, USA.
² Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA.
³ Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Editorial

Chan Yeu Pu et al. J Thorac Dis. 2019 Dec.

. 2019 Dec;11(12):5646-5648.

doi: 10.21037/jtd.2019.11.23.

Chan Yeu Pu¹, Sai Yendamuri^{2

3}

¹ Pulmonary, Critical Care and Sleep Division, Department of Medicine, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, NY, USA.
² Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, NY, USA.
³ Department of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
Brandt WS, Yan W, Zhou J, Tan KS, Montecalvo J, Park BJ, Adusumilli PS, Huang J, Bott MJ, Rusch VW, Molena D, Travis WD, Kris MG, Chaft JE, Jones DR. Brandt WS, et al. J Thorac Cardiovasc Surg. 2019 Feb;157(2):743-753.e3. doi: 10.1016/j.jtcvs.2018.09.098. Epub 2018 Oct 10. J Thorac Cardiovasc Surg. 2019. PMID: 30415902 Free PMC article.

1. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-9. 10.1200/JCO.2007.13.9030 - DOI - PubMed
1. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60. 10.1056/NEJMoa031644 - DOI - PubMed
1. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97. 10.1056/NEJMoa043623 - DOI - PubMed
1. NSCLC Meta-analyses Collaborative Group , Arriagada R, Auperin A, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010;375:1267-77 10.1016/S0140-6736(10)60059-1 - DOI - PMC - PubMed
1. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-27. Erratum in: Lancet Oncol 2006;7:797. 10.1016/S1470-2045(06)70804-X - DOI - PubMed